Intraarterial Contrast-Enhanced Ultrasonography Is the Final Goal of Intravenous Contrast-Enhanced Ultrasonography

  • Masatoshi Kudo


Contrast-enhanced ultrasonography (US) falls into two broad categories: intraarterial and intravenous (Table 1–1). Intraarterial techniques use CO2 microbubbles as the contrast agent, whereas intravenous techniques use Levovist (300 mg/ml), the only contrast agent currently marketed in Japan. Intravenous contrast-enhanced US can be further classified into contrast-enhanced Doppler and contrastenhanced harmonic techniques. The former utilizes fundamental wave color Doppler or power Doppler. The latter utilizes harmonics, and can be either harmonic color or power Doppler, or harmonic B-mode. Because different types of equipment perform differently, the selection of techniques is currently based on equipment availability.1


Focal Nodular Hyperplasia Conventional Angiography Equipment Availability Surrounding Liver Parenchyma Contrast Harmonic Image 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kudo M: Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions. Semin Liver Dis 1999; 19:297–309PubMedCrossRefGoogle Scholar
  2. 2.
    Kudo M: Ultrasound diagnosis. In: Liver Cancer, Okuda K, Tabor E, eds, Churchill Livingstone, London, 1997; 331–346Google Scholar
  3. 3.
    Matsuda Y, Yabuuchi I: Hepatic tumors: US contrast enhancement with CO2 microbubbles. Radiology 1986; 161:701–705PubMedGoogle Scholar
  4. 4.
    Kudo M, Tomita S, Tochio H, et al: Small hepatocellular carcinoma: diagnosis with US angiography with intraarterial CO2 microbubbles. Radiology 1992; 182:155–160PubMedGoogle Scholar
  5. 5.
    Kudo M, Tomita S, Tochio H, et al: Sonography with intraarterial infusion of carbon dioxide microbubbles (sonographic angiography): value in differential diagnosis of hepatic tumors. AJR 1992; 158:65–74PubMedGoogle Scholar
  6. 6.
    Kudo M, Tomita S, Tochio H, et al: Hepatic focal nodular hyperplasia: specific findings at dynamic contrast-enhanced US with carbon dioxide microbubbles. Radiology 1991; 179:377–382PubMedGoogle Scholar
  7. 7.
    Kudo M: Morphological diagnosis of hepatocellular carcinoma: special emphasis on intranodular hemodynamic imaging. Hepato-Gastroenterology 1998; 45:1226–1231PubMedGoogle Scholar
  8. 8.
    Kudo M: Imaging blood flow characteristics of hepatocellular carcinoma. Oncology 2002; 62(Suppl l):48–56PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2003

Authors and Affiliations

  • Masatoshi Kudo
    • 1
  1. 1.Department of Gastroenterology and HepatologyKinki University School of MedicineOsakaJapan

Personalised recommendations